These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34298450)
1. Preoperative leukocytosis correlates with unfavorable pathological and survival outcomes in endometrial carcinoma: A systematic review and meta-analysis. Abu-Zaid A; Alomar O; Baradwan S; Abuzaid M; Alshahrani MS; Allam HS; Alqarni SMS; Nazer A; Salem H; Al-Badawi IA Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():88-96. PubMed ID: 34298450 [TBL] [Abstract][Full Text] [Related]
2. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis. Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973 [TBL] [Abstract][Full Text] [Related]
3. Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia. Salem H; Abu-Zaid A; Aloman O; Abuzaid M; Alsabban M; Elhassan T; Salem A; Alyamani Y; Al-Badawi IA Gulf J Oncolog; 2020 Jan; 1(32):51-58. PubMed ID: 32342919 [TBL] [Abstract][Full Text] [Related]
4. The significance of preoperative leukocytosis in endometrial carcinoma. Worley MJ; Nitschmann CC; Shoni M; Vitonis AF; Rauh-Hain JA; Feltmate CM Gynecol Oncol; 2012 Jun; 125(3):561-5. PubMed ID: 22465698 [TBL] [Abstract][Full Text] [Related]
5. Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Worley MJ; Nitschmann CC; Shoni M; Rauh-Hain JA; Williams KA; Feltmate CM Int J Gynecol Cancer; 2013 Feb; 23(2):312-7. PubMed ID: 23358179 [TBL] [Abstract][Full Text] [Related]
6. [Clinical implications of positive peritoneal cytology in endometrial cancer]. Ren YL; Wang HY; Shan BE; Ping B; Shi DR Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values of human epididymis protein 4 expression in patients with endometrial cancer: A systematic review and meta-analysis. Han LN; Han YW; Yan P J Obstet Gynaecol Res; 2022 Sep; 48(9):2255-2269. PubMed ID: 35844088 [TBL] [Abstract][Full Text] [Related]
8. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma. Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117 [TBL] [Abstract][Full Text] [Related]
9. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095 [TBL] [Abstract][Full Text] [Related]
10. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma. Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma. Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article). Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583 [TBL] [Abstract][Full Text] [Related]
13. p53 overexpression as a prognostic indicator in endometrial carcinoma. Ozalp S; Yalcin OT; Tanir HM; Kabukcuoglu S; Erol G Eur J Gynaecol Oncol; 2003; 24(3-4):275-8. PubMed ID: 12807239 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. Zhu J; Wen H; Bi R; Wu X J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439 [TBL] [Abstract][Full Text] [Related]
15. Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance. López-González E; Rodriguez-Jiménez A; Gómez-Salgado J; Daza-Manzano C; Rojas-Luna JA; Alvarez RM Int J Gynaecol Obstet; 2023 Dec; 163(3):840-846. PubMed ID: 37350418 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
17. Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer. Yokoi E; Mabuchi S; Komura N; Shimura K; Matsumoto Y; Kimura T Int J Gynaecol Obstet; 2020 Nov; 151(2):272-278. PubMed ID: 32712993 [TBL] [Abstract][Full Text] [Related]
18. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293 [TBL] [Abstract][Full Text] [Related]
19. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma]. Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640 [TBL] [Abstract][Full Text] [Related]
20. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer. Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]